Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efficacy of Hemostatic Agents”

706 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 706 results

Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Large-scale testing (Phase 3)Study completedNCT02615691
What this trial is testing

PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 120
Very early researchLooking for participantsNCT06045091
What this trial is testing

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Hrain Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Testing effectiveness (Phase 2)Study completedNCT00396331
What this trial is testing

AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts

Who this might be right for
Autologous Stem Cell Transplantation
Genzyme, a Sanofi Company 100
Testing effectiveness (Phase 2)Looking for participantsNCT06087653
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Starton Therapeutics, Inc 24
Large-scale testing (Phase 3)UnknownNCT02769754
What this trial is testing

Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection

Who this might be right for
Liver DamageSurgery
Instituto de Investigacion Sanitaria La Fe 250
Not applicableStudy completedNCT01314963
What this trial is testing

Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy

Who this might be right for
Multiple MyelomaBreast Cancer
Stanford University 50
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Very early researchLooking for participantsNCT07249073
What this trial is testing

CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Large-scale testing (Phase 3)Looking for participantsNCT06918002
What this trial is testing

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome 824
Testing effectiveness (Phase 2)Study completedNCT05561751
What this trial is testing

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
GPCR Therapeutics, Inc. 30
Not applicableEnded earlyNCT02291965
What this trial is testing

Blood Samples to Identify Biomarkers of Busulfan

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Fred Hutchinson Cancer Center 139
Large-scale testing (Phase 3)Ended earlyNCT00083564
What this trial is testing

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Poniard Pharmaceuticals 240
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Large-scale testing (Phase 3)Study completedNCT01311687
What this trial is testing

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

Who this might be right for
Multiple Myeloma
Celgene 455
Not applicableLooking for participantsNCT04398628
What this trial is testing

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Who this might be right for
Hematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more
American Thrombosis and Hemostasis Network 3,000
Very early researchUnknownNCT03559764
What this trial is testing

Study of BCMA CAR-T in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Allife Medical Science and Technology Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05002816
What this trial is testing

Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Yale University 24
Next Page